Literature DB >> 9131763

Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis.

B J Biggerstaff1, R L Tweedie.   

Abstract

When combining results from separate investigations in a meta-analysis, random effects methods enable the modelling of differences between studies by incorporating a heterogeneity parameter tau 2 that accounts explicitly for across-study variation. We develop a simple form for the variance of Cochran's homogeneity statistic Q, leading to interval estimation of tau 2 utilizing an approximating distribution for Q; this enables us to extend the point estimation of DerSimonian and Laird. We also develop asymptotic likelihood methods and compared them with this method. We then use these approximating distributions to give a new method of calculating the weight given to the individual studies' results when estimating the overall mean which takes into account variation in these point estimates of tau 2. Two examples illustrate the methods presented, where we show that the new weighting scheme is between the standard fixed and random effects models in down-weighting the results of large studies and up-weighting those of small studies.

Mesh:

Year:  1997        PMID: 9131763     DOI: 10.1002/(sici)1097-0258(19970415)16:7<753::aid-sim494>3.0.co;2-g

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  61 in total

1.  Maternal smoking and the risk of early weaning: a meta-analysis.

Authors:  B L Horta; M S Kramer; R W Platt
Journal:  Am J Public Health       Date:  2001-02       Impact factor: 9.308

2.  Confidence intervals for heterogeneity measures in meta-analysis.

Authors:  Bahi Takkouche; Polyna Khudyakov; Julián Costa-Bouzas; Donna Spiegelman
Journal:  Am J Epidemiol       Date:  2013-08-06       Impact factor: 4.897

3.  A new approach to outliers in meta-analysis.

Authors:  Rose Baker; Dan Jackson
Journal:  Health Care Manag Sci       Date:  2008-06

4.  Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies.

Authors:  Buhm Han; Eleazar Eskin
Journal:  Am J Hum Genet       Date:  2011-05-13       Impact factor: 11.025

5.  Genome-wide meta-analysis of copy number variations with alcohol dependence.

Authors:  A Sulovari; Z Liu; Z Zhu; D Li
Journal:  Pharmacogenomics J       Date:  2017-07-11       Impact factor: 3.550

6.  A framework for the meta-analysis of Bland-Altman studies based on a limits of agreement approach.

Authors:  Elizabeth Tipton; Jonathan Shuster
Journal:  Stat Med       Date:  2017-06-29       Impact factor: 2.373

7.  Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradication.

Authors:  K Agro; G Blackhouse; R Goeree; A R Willan; J Q Huang; R H Hunt; B J O'Brien
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 8.  Endotoxin exposure and lung cancer risk: a systematic review and meta-analysis of the published literature on agriculture and cotton textile workers.

Authors:  Virissa Lenters; Ioannis Basinas; Laura Beane-Freeman; Paolo Boffetta; Harvey Checkoway; David Coggon; Lützen Portengen; Malcolm Sim; Inge M Wouters; Dick Heederik; Roel Vermeulen
Journal:  Cancer Causes Control       Date:  2009-12-12       Impact factor: 2.506

9.  A re-evaluation of random-effects meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson; David J Spiegelhalter
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2009-01       Impact factor: 2.483

10.  Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.

Authors:  Dan Jackson; Ian White; J B Kostis; A C Wilson; A R Folsom; K Wu; L Chambless; M Benderly; U Goldbourt; J Willeit; S Kiechl; J W G Yarnell; P M Sweetnam; P C Elwood; M Cushman; B M Psaty; R P Tracy; A Tybjaerg-Hansen; F Haverkate; M P M de Maat; S G Thompson; F G R Fowkes; A J Lee; F B Smith; V Salomaa; K Harald; V Rasi; E Vahtera; P Jousilahti; R D'Agostino; W B Kannel; P W F Wilson; G Tofler; D Levy; R Marchioli; F Valagussa; A Rosengren; L Wilhelmsen; G Lappas; H Eriksson; P Cremer; D Nagel; J D Curb; B Rodriguez; K Yano; J T Salonen; K Nyyssönen; T-P Tuomainen; B Hedblad; G Engström; G Berglund; H Loewel; W Koenig; H W Hense; T W Meade; J A Cooper; B De Stavola; C Knottenbelt; G J Miller; J A Cooper; K A Bauer; R D Rosenberg; S Sato; A Kitamura; Y Naito; H Iso; V Salomaa; K Harald; V Rasi; E Vahtera; P Jousilahti; T Palosuo; P Ducimetiere; P Amouyel; D Arveiler; A E Evans; J Ferrieres; I Juhan-Vague; A Bingham; H Schulte; G Assmann; B Cantin; B Lamarche; J-P Despres; G R Dagenais; H Tunstall-Pedoe; G D O Lowe; M Woodward; Y Ben-Shlomo; G Davey Smith; V Palmieri; J L Yeh; T W Meade; A Rudnicka; P Brennan; C Knottenbelt; J A Cooper; P Ridker; F Rodeghiero; A Tosetto; J Shepherd; G D O Lowe; I Ford; M Robertson; E Brunner; M Shipley; E J M Feskens; E Di Angelantonio; S Kaptoge; S Lewington; G D O Lowe; N Sarwar; S G Thompson; M Walker; S Watson; I R White; A M Wood; J Danesh
Journal:  Stat Med       Date:  2009-04-15       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.